Skip to content

Comparison of the effects of esketamine and sufentanil on the incidence of intraoperative hypoxemia during bronchoscopy

Comparison of the effects of esketamine and sufentanil on the incidence of intraoperative hypoxemia during bronchoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058990
Enrollment
Unknown
Registered
2022-04-22
Start date
2022-04-22
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia

Interventions

esketamine group:Intravenous administration of esketamine
sufentanil group:Intravenous administration of sufentanil

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Selective electronic bronchoscopy; 3. ASA 1-3.

Exclusion criteria

Exclusion criteria: 1. SpO2 after preoperative oxygenation was lower than 90%. 2. Have a history of depression or take antidepressants. 3. History of neuropsychiatric disorders or substance abuse. 4. Unable to cooperate with scale evaluation. 5. Abnormal liver and kidney function. 6. History of hyperthyroidism. 7. Severe adverse reactions, such as intraoperative cardiac arrest and CPR. 8. Severe hypertension, intraocular pressure or intracranial pressure.

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative hypoxemia;

Secondary

MeasureTime frame
Severe intraoperative hypoxemia;Duration of hypoxemia;Hypotension or bradycardia;The number of intraoperative choking coughs and incidence of body movements;Quality of awakening;Delirium;Postoperative nausea and vomiting;Patients satisfaction;

Countries

China

Contacts

Public ContactWu Anshi
wuanshi99@163.com+86 10 85231330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026